Pirfenidone Side Effects and Management: A Practical IPF Guide
Medically reviewed/updated: August 2026 Starting an antifibrotic treatment can raise an important question for people living with idiopathic pulmonary fibrosis (IPF): What will pirfenidone feel like, and what can I do if side effects appear? Pirfenidone is a prescription antifibrotic medicine used to treat adults with IPF. If you are new to this medication, our […]
Living With Pulmonary Fibrosis While Taking Pirfenidone: 7 Lifestyle Tips, Diet & Daily Care
Medically reviewed/updated: August 2026 Living with pulmonary fibrosis can change the way you approach exercise, meals, work, travel and everyday activities. When pirfenidone is part of your treatment plan, lifestyle habits become especially important because managing pulmonary fibrosis involves more than taking medication alone. Pulmonary fibrosis is a group of conditions in which lung tissue […]
Pirfenidone 200 mg and 400 mg Tablets for IPF: Complete Guide
Medically reviewed/updated: August 2026 When researching treatment for idiopathic pulmonary fibrosis (IPF), patients may encounter pirfenidone tablets in different strengths. Pirfenidone 200 mg and 400 mg tablets for IPF contain the same active medicine, but each tablet provides a different amount of pirfenidone. This difference can create an important question: What is the difference between […]
Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): Complete Guide
Medically reviewed/updated: August 2026 Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease in which scar tissue gradually builds up in the lungs, making them stiffer and making breathing increasingly difficult. Although there is currently no cure that reverses established IPF scarring, antifibrotic medicines can help slow disease progression in appropriate patients. The NHS explains […]
What Is Pirfenidone? Uses, Dosage, Side Effects & Safety Guide
Medically reviewed/updated: August 2026 Pirfenidone is a prescription antifibrotic medicine used primarily to treat idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes progressive scarring of lung tissue. By slowing processes involved in fibrosis, pirfenidone may help slow the decline in lung function in people with IPF. Idiopathic pulmonary fibrosis is one example of […]